![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/19/2901306/0/en/Avicanna-General-Meeting.html
https://www.globenewswire.com/news-release/2024/06/19/2901060/0/en/Avicanna-Announces-USPTO-Issuance-of-Patent-SEDDS-Technology.html
https://www.globenewswire.com/news-release/2024/06/18/2900317/0/en/Avicanna-to-Present-at-the-Life-Science-Investor-Forum-June-20th-2024.html
https://www.globenewswire.com/news-release/2024/05/14/2881286/0/en/Avicanna-Reports-Q1-2024-and-First-Positive-Adjusted-EBIDTA-Quarter.html
https://www.globenewswire.com/news-release/2024/05/13/2880330/0/en/Avicanna-Announces-Results-of-Study-in-Patients-with-Epidermolysis-Bullosa.html
https://www.globenewswire.com/news-release/2024/04/18/2865867/0/en/Avicanna-Announces-Closing-of-Non-brokered-Private-Placement.html
https://www.globenewswire.com/news-release/2024/04/10/2860755/0/en/Avicanna-Announces-Completion-of-Topical-Gel-Observational-Real-World-Evidence-Study.html
https://www.globenewswire.com/news-release/2024/04/02/2855840/0/en/Avicanna-Reports-Full-Year-2023-Audited-Financial-Results.html
https://www.globenewswire.com/news-release/2024/03/27/2853129/0/en/Avicanna-Announces-the-Canadian-Launch-of-10-CBD-THC-Free-Proprietary-Formulation.html
https://www.globenewswire.com/news-release/2024/03/26/2852255/0/en/Avicanna-To-Hold-Full-Year-2023-Earnings-Conference-Call.html